Jennison Associates LLC Increases Holdings in Sotera Health Company $SHC

Jennison Associates LLC raised its stake in shares of Sotera Health Company (NASDAQ:SHC) by 31.1% in the first quarter, Holdings Channel.com reports. The institutional investor owned 1,836,746 shares of the company’s stock after buying an additional 435,384 shares during the quarter. Jennison Associates LLC’s holdings in Sotera Health were worth $26,339,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. IFP Advisors Inc grew its holdings in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares during the period. Rothschild Investment LLC bought a new position in Sotera Health in the fourth quarter valued at about $27,000. Root Financial Partners LLC lifted its holdings in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after acquiring an additional 1,455 shares during the period. True Wealth Design LLC boosted its position in Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after purchasing an additional 1,456 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the last quarter. 91.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on SHC shares. UBS Group set a $19.00 price target on Sotera Health in a research note on Wednesday, June 24th. Piper Sandler reissued an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Barclays boosted their target price on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Weiss Ratings upgraded shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $17.42 on Tuesday. The company has a market capitalization of $4.97 billion, a P/E ratio of 42.49 and a beta of 1.76. Sotera Health Company has a 1-year low of $10.98 and a 1-year high of $19.85. The firm’s 50 day simple moving average is $16.50 and its two-hundred day simple moving average is $16.40. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Research analysts expect that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 15.36% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.